Oncotarget: Providing a Platform for Scientists to Speak

Oncotarget is one of the most important inventions in the world of medicine. The online medical journal was first developed into a concept by Mikhail Blagosklonny and Andrei Gudkov. The two are working as oncologists for the Roswell Park Cancer Institute. Mikhail Blagosklonny and Andrei Gudkov are known for their extensive research about immortality, and they even developed a drug made from rapamycin which can be used as a supplement to regain a youthful look. Oncotarget first went live in 2010, and since their introduction to the internet, more and more curious people have visited the website and read some of the articles published. Download output styles at Endnote.com.

Being one of the first peers to peer online medical journals, writers refer to Oncotarget as a place where it is too difficult to write an insight or study. Writers who are working with Oncotarget would have their pieces sent to a group of scientists who will be reviewing the paper. This is what the peer to peer review means, and once the scientists discovered that the article is neat and clean, they will be sending it to Mikhail Blagosklonny and Andrei Gudkov, the editors in chief, for further review and approval. Oncotarget has been the most favorite place for scientists to hang out, and they have thanked Mikhail Blagosklonny and Andrei Gudkov for creating a platform where they can speak freely with one another and exchange electronic documents in an instant. Learn more at researchgate.net


The online medical journal posts information and news about cancer. Recently, Oncotarget sent four types of research who are also working as scientists to a conference in Singapore. They will be speaking about the current status of the research for a cancer cure, and they will also introduce some of the latest treatment options for patients who have cancer. Oncotarget changed a lot of lives, and the creators are pleased about it. Mikhail Blagosklonny and Andrei Gudkov stated that they are hoping that in the future, Oncotarget will be the norm for scientists who are working to eradicate diseases that plagued humanity since prehistory.

Visit: https://oncotarget.msubmit.net/cgi-bin/main.plex